Renata started her career in academia at St Thomas’s Hospital, London working on cardiovascular research and heart transplantation. She joined the Drug Development Department at Roche, gaining over 30 years extensive experience in the scientific and clinical development field, regulatory approval and commercialisation of new medicines. The majority of Renata’s pharmaceutical career was spent in early clinical development, initially as a Clinical Pharmacologist in the CVS, Infectious Diseases, and CNS therapeutic areas. She then went on to leading the Clinical Pharmacology Operations Group, responsible for delivery of all Roche Clinical Pharmacology Programmes. As a Project Leader, she led project teams at all stages of development from the early discovery phase to life-cycle management for Roche’s key projects including Tamiflu the influenza drug, Avastin and Obinutuzumab Oncology molecules. Renata’s most recent role at Roche was as the Global Head of Early Development Clinical Operations and Deputy Head of Early Development. She joined Cancer Research UK in early 2015 to contribute her broad knowledge of drug, and particularly, oncology drug development to support the CRUK drug development programmes. Here, she headed up the Study, Project and Portfolio Management Group.